|
About the Frequently Asked Questions category
|
|
0
|
30
|
8 March 2021
|
|
In the Open Targets Genetics Portal, what is the “credible set overlap”?
|
|
0
|
4
|
22 July 2021
|
|
How to interpret Variant-to-Gene (V2G) and Locus-to-Gene (L2G) scores in the Open Targets Genetics Portal
|
|
0
|
18
|
19 July 2021
|
|
What fine-mapping and colocalisation software does the Open Targets Genetics Portal use?
|
|
0
|
13
|
14 July 2021
|
|
How are tag variants identified in the Open Targets Genetics Portal?
|
|
0
|
20
|
12 July 2021
|
|
How are UK Biobank study traits identified in the Genetics Portal?
|
|
0
|
20
|
7 July 2021
|
|
What is the difference between the Open Targets Platform and the Open Targets Genetics Portal?
|
|
0
|
39
|
16 June 2021
|
|
What happened to the batch search functionality?
|
|
7
|
187
|
28 June 2021
|
|
Score values from Disease->Target vs. Target->Disease
|
|
3
|
55
|
25 June 2021
|
|
Batch query for biomarker prioritization
|
|
1
|
83
|
13 May 2021
|
|
Why doesn't the Platform distinguish between diseases and phenotypes?
|
|
0
|
45
|
6 May 2021
|
|
What ontology is used for disease and phenotype terms?
|
|
0
|
49
|
8 March 2021
|
|
How can I view diseases and phenotypes associated with a given target?
|
|
0
|
53
|
8 March 2021
|
